Every 8-K that PROTO LABS, INC. (PRLB) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow PRLB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PRLB filings page.
Proto Labs Inc (PRLB) announced that it has appointed Sam Ramahi as Chief Operations Officer, effective August 31, 2026. Ramahi will lead global operations, supply chain, quality, sourcing, and continuous improvement, reporting to President and Chief Executive Officer Suresh Krishna, who will retain ultimate oversight of operations.
The company highlights Ramahi’s more than 25 years of executive operational leadership across global industrial and manufacturing businesses, including prior roles at SIG Group, Jacuzzi Group, nVent, Eaton, Cooper Industries, Honeywell, and GE Healthcare. A related press release is furnished as Exhibit 99.1 and treated as non-filed information under the Exchange Act.
Proto Labs, Inc. reported record revenue of $149.3 million for the quarter ended June 30, 2026, a 10.6% increase over the second quarter of 2025, driven by double-digit growth in CNC machining and injection molding. GAAP diluted EPS was $0.37 and non-GAAP diluted EPS was $0.60.
Profitability improved, with GAAP gross margin rising to 46.4% and GAAP operating margin to 7.6%, while non-GAAP operating margin reached 12.0%. Adjusted EBITDA was $25.1 million, or 16.8% of revenue. Cash and investments totaled $162.9 million, supported by $15.4 million of cash generated from operations in the quarter.
Management raised full-year 2026 revenue growth guidance from 6%–8% to 8%–10%. For the third quarter of 2026, the company expects revenue between $145.0 million and $153.0 million, with GAAP diluted EPS of $0.34–$0.42 and non-GAAP diluted EPS of $0.56–$0.64.
Proto Labs, Inc. reported the results of its Annual Meeting of Shareholders. Investors approved an amendment to the Amended and Restated 2022 Long-Term Incentive Plan, adding 395,000 shares available for equity awards to employees and directors.
Shareholders elected all seven board nominees, ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, and supported executive compensation in an advisory vote. They also chose an annual frequency for future advisory votes on executive pay.
Proto Labs, Inc. announced an executive leadership transition. Chief Operations Officer Michael R. Kenison plans to retire effective July 1, 2026 after a long tenure helping expand the company’s global manufacturing footprint.
The company appointed Bernardo Parlange as its first Chief Commercial Officer, effective May 18, 2026. In this newly created role, he will lead global commercial strategy across sales, marketing, and customer success, with a focus on revenue growth, stronger strategic customer relationships, and enhancing the customer experience. These changes were detailed in an accompanying press release furnished as an exhibit.
Proto Labs, Inc. reported strong first quarter 2026 results with record revenue of $139.3 million, up 10.4% from the first quarter of 2025. GAAP diluted earnings per share were $0.33, more than double the prior year’s $0.15, while non-GAAP diluted earnings per share rose to $0.54 from $0.33.
CNC machining revenue grew 19.7% year-over-year, and revenue per customer contact increased 20.4%, showing customers are spending more per order even as total contacts declined. Non-GAAP gross margin improved to 46.2% of revenue and Adjusted EBITDA margin increased to 16.3%, reflecting better profitability.
The company generated $17.5 million in cash from operations and held $158.0 million in cash and investments as of March 31, 2026. For full-year 2026, Proto Labs expects revenue growth between 6% and 8%. For the second quarter 2026, it forecasts revenue of $140.0–$148.0 million, GAAP diluted earnings per share of $0.29–$0.37, and non-GAAP diluted earnings per share of $0.50–$0.58.
Proto Labs, Inc. filed an amended current report to correct a guidance figure in its previously issued outlook. The amendment clarifies that the company’s GAAP diluted earnings per share guidance range for the first quarter of 2026 is $0.18 to $0.26, instead of the $0.17 to $0.25 range originally described in the attached press release. No other aspects of the earlier report or the press release were changed, and the correction is described as a scrivener’s error.
Proto Labs, Inc. reported record fourth-quarter 2025 revenue of $136.5 million, up 12.1% from a year ago, and returned to profitability with net income of $6.0 million, or $0.25 per diluted share, versus a small loss last year. Non-GAAP net income was $10.7 million, or $0.44 per diluted share.
For full year 2025, revenue reached a record $533.1 million, a 6.4% increase, with net income rising to $21.2 million, or $0.88 per diluted share. CNC Machining led growth, while 3D Printing and Injection Molding declined slightly. Adjusted EBITDA was $78.1 million, a 14.7% margin, and operating cash flow was $74.5 million, supporting a year-end cash and investments balance of $142.4 million.
Management highlighted four strategic pillars—elevating customer experience, accelerating innovation, expanding production, and driving operational efficiency—and issued 2026 guidance calling for 6% to 8% revenue growth. For Q1 2026, the company expects revenue of $130.0 million to $138.0 million and diluted EPS of $0.17 to $0.25, or $0.36 to $0.44 on a non-GAAP basis.
Proto Labs, Inc. (PRLB) furnished an 8-K announcing its third quarter 2025 financial results. The company reported the news via a press release that is attached to the filing as Exhibit 99.1 and incorporated by reference.
The filing is administrative in nature and points readers to the press release for the full results.
Proto Labs, Inc. reported a leadership change in its technology organization. On October 3, 2025, the company announced that Chief Technology Officer Oleg Ryaboy will depart and cease to be an employee effective November 2, 2025, and is no longer an executive officer as of that notice date.
Marc Kermisch has been appointed as the new Chief Technology & AI Officer, effective October 13, 2025, marking a transition that adds explicit responsibility for artificial intelligence. Upon departure, Mr. Ryaboy will receive severance benefits under the company’s existing Form of Executive Severance Agreement. The company also issued a press release detailing this leadership transition.